Claims relating to statements about artificial intelligence (“AI”) have rapidly become a focal point in securities litigation. Similar to the past surge of “greenwashing” claims tied to climate change disclosures, in 2024 we...more
4/1/2025
/ Artificial Intelligence ,
Initial Public Offering (IPO) ,
Misleading Statements ,
Misrepresentation ,
Pending Litigation ,
Publicly-Traded Companies ,
Rule 10b-5 ,
Securities Act of 1933 ,
Securities Exchange Act ,
Securities Fraud ,
Securities Litigation ,
Shareholders
On April 12, 2024, the U.S. Supreme Court took a significant step to curb securities fraud suits based on alleged omissions in SEC filings. The Supreme Court held in Macquarie Infrastructure Corporation v. Moab Partners, L.P....more
As COVID-19 has continued to spread across the United States, the Securities and Exchange Commission (SEC) has remained keenly focused on monitoring the market “for frauds, illicit schemes and other misconduct affecting U.S....more
While the global pandemic may have disrupted many industries, it has not stopped plaintiffs from continuing to file COVID-19-related securities fraud class actions under Section 10(b) of the Securities Exchange Act. As we...more
In the wake of recent unexpected changes in the way that companies do business, the goods and services that consumers demand, and the accompanying market volatility, plaintiffs have begun filing securities fraud complaints...more
5/4/2020
/ Class Action ,
Coronavirus/COVID-19 ,
Cruise Ships ,
Disclosure Requirements ,
False Statements ,
Material Misstatements ,
Pharmaceutical Industry ,
Securities Exchange Act ,
Securities Fraud ,
Securities Litigation ,
Virus Testing ,
Zoom®